HIV i-Base report from the 6th Joint Conference of the British HIV Association (BHIVA) and the British Association for Sexual Health and HIV (BASHH)
Several studies at the 6th Joint BHIVA/BASHH conference presented new data from the rollout of doxyPEP to protect against syphilis and chlamydia.
The first was a retrospective study of drug resistance against gonorrhoea from expanded access to doxyPEP.
A second study looked at equity of access to doxyPEP several months after it had been made widely available.
Two related posters were also presented: the first reported on the potential of doxyPEP to reduce syphilis and chlamydia in gay and bisexual men and trans women who have sex with men and the second estimated the numbers needed for the 4CMenB to impact rates of gonorrhoea.
Read more here.
Source : HIV i-Base
Related HIV and Co-Infections News
-
[CROI 2026] HIV i-Base: Nine comprehensive free reviews in Topics in Antiviral Medicine
-
[BHIVA/BASHH 2026] HIV i-Base: Liverpool University launches new PrEP drug interaction website: covers oral, injectable and ring-based PrEP
-
HIV i-Base: Transgender health in Australia: HIV drops by 94% as PrEP increases over 10 years
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.